{"corpus_id":2758151,"paper_sha":"fc247fd42014c021b532d6713f2dd6e9e1cd20e7","doi":"10.1186/s13019-015-0270-5","arxiv_id":null,"pmid":25947235,"pmcid":"4423097","mag_id":2033139717,"dblp_id":null,"acl_id":null,"title":"Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion","year":2015,"publication_date":"2015-05-01","venue":"Journal of Cardiothoracic Surgery","journal":{"name":"Journal of Cardiothoracic Surgery","pages":null,"volume":"10"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle","Study"],"pubmed_pub_types":["Comparative Study","Journal Article","Randomized Controlled Trial"],"s2_fields_of_study":["Medicine"],"reference_count":21,"citation_count":38,"influential_citation_count":2,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Aged, 80 and over","mj":false,"ui":"D000369"},{"d":"Breast Neoplasms","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"}],"ui":"D001943"},{"d":"Chest Tubes","mj":false,"ui":"D015505"},{"d":"Chi-Square Distribution","mj":false,"ui":"D016009"},{"d":"Dyspnea","mj":false,"qs":[{"q":"etiology","mj":false,"ui":"Q000209"}],"ui":"D004417"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Length of Stay","mj":false,"ui":"D007902"},{"d":"Lung Neoplasms","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"}],"ui":"D008175"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Palliative Care","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D010166"},{"d":"Pleural Effusion, Malignant","mj":false,"qs":[{"q":"etiology","mj":false,"ui":"Q000209"},{"q":"therapy","mj":true,"ui":"Q000628"}],"ui":"D016066"},{"d":"Pleurodesis","mj":false,"qs":[{"q":"methods","mj":true,"ui":"Q000379"}],"ui":"D018700"},{"d":"Povidone-Iodine","mj":false,"qs":[{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D011206"},{"d":"Prospective Studies","mj":false,"ui":"D011446"},{"d":"Quality of Life","mj":false,"ui":"D011788"},{"d":"Talc","mj":false,"qs":[{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D013627"},{"d":"Thoracentesis","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D000069258"},{"d":"Treatment Outcome","mj":false,"ui":"D016896"}],"chemicals":[{"n":"Talc","ui":"D013627","reg":"14807-96-6"},{"n":"Povidone-Iodine","ui":"D011206","reg":"85H0HZU99M"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://cardiothoracicsurgery.biomedcentral.com/counter/pdf/10.1186/s13019-015-0270-5","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/fc247fd42014c021b532d6713f2dd6e9e1cd20e7","s2_open_access_license":"CCBY","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"BackgroundMalignant pleural effusions continue to be a common problem in patients with metastatic disease, leading to a significant reduction in quality of life with progressive dyspnea, dry cough, chest pain and reduced physical activity. This study was conducted to compare the efficacy, safety, and outcome of Talc Powder Pleurodesis (TPP) with Povidone-iodine Pleurodesis (PIP) through a chest drain as a palliative preventive treatment of recurrent malignant pleural effusion.MethodsA total of 39 neoplastic patients with recurrent malignant pleural effusion were enrolled in a prospective randomized trial. Twenty-one patients received Talc pleurodesis (group A), and eighteen patients (group B) received Povidone-iodine pleurodesis. The continuous variables were expressed as mean values ± standard deviation (SD) and compared using the unpaired t-test. The discrete variables were expressed as percentage and compared using the chi-square test (χ2) test. p-values of less than 0.05 were considered significant.ResultsOur study included 11 males and 28 females, the mean age was (71.0 ± 5.0) years for group A and (70.9 ± 5.1) years for group B (non-significant). Post-procedure analgesic requirements were recorded in both groups. Four patients in each group had fever (>38°C) within 48 hours of the procedure. Both groups achieved good symptomatic relief. There were no in-hospital deaths. The mean post-procedure hospital stay was (4.7 ± 1.2) days for group A and (4.2 ± 1.0) for group B (non-significant). At follow-up recurrence of significant pleural effusion requiring intervention was noted in four and five patients in group A and group B, respectively (non-significant difference).ConclusionPovidone-iodine pleurodesis can be considered as a good alternative to Talc pleurodesis for recurrent malignant pleural effusion. The drug is available, cost effective, safe and can be administered through an intercostal drain and repeated if necessary.","claims":[{"public_id":"cl_eb38b64539a093833cca1868fb51a4a8","status":"active","text":"A prospective randomized trial enrolled 39 neoplastic patients with recurrent malignant pleural effusion and compared Talc Powder Pleurodesis with Povidone-iodine Pleurodesis through a chest drain.","confidence":0.98,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/claims/cl_eb38b64539a093833cca1868fb51a4a8"},{"public_id":"cl_9efc643254fed8eb29cc57f5b68d0494","status":"active","text":"Both Talc Powder Pleurodesis and Povidone-iodine Pleurodesis achieved good symptomatic relief without in-hospital deaths.","confidence":0.93,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/claims/cl_9efc643254fed8eb29cc57f5b68d0494"},{"public_id":"cl_931e76e8d8ec621a53de8176b6c64d5b","status":"active","text":"Mean post-procedure hospital stay was 4.7 days after Talc Powder Pleurodesis and 4.2 days after Povidone-iodine Pleurodesis, with a non-significant difference.","confidence":0.94,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/claims/cl_931e76e8d8ec621a53de8176b6c64d5b"},{"public_id":"cl_16f5da412003b92aaa5ce568cd66328a","status":"active","text":"Post-procedure fever within 48 hours occurred in four patients in each treatment group.","confidence":0.95,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/claims/cl_16f5da412003b92aaa5ce568cd66328a"},{"public_id":"cl_6d735c99e17ce82bd5d6cfb073e9e171","status":"active","text":"Recurrence of significant pleural effusion requiring intervention occurred in four patients after Talc Powder Pleurodesis and five patients after Povidone-iodine Pleurodesis, with a non-significant difference.","confidence":0.95,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/claims/cl_6d735c99e17ce82bd5d6cfb073e9e171"}],"concepts":[{"public_id":"co_004eccb1e755de3d6399012d43d31bca","status":"active","name":"chest drain","description":"The intercostal drainage route used to administer the pleurodesis agents.","types":["delivery route"],"aliases":["intercostal drain"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_004eccb1e755de3d6399012d43d31bca"},{"public_id":"co_0da025075a04e9a5908d71f8d62338ff","status":"active","name":"post-procedure hospital stay","description":"The duration of hospitalization after the pleurodesis procedure, reported in days.","types":["clinical outcome"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_0da025075a04e9a5908d71f8d62338ff"},{"public_id":"co_1927620e2e102be4216656dc48a4694f","status":"active","name":"neoplastic patients","description":"Patients with cancer-related disease enrolled in the pleurodesis comparison.","types":["patient population"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_1927620e2e102be4216656dc48a4694f"},{"public_id":"co_24a56c91850d55fdd8b810db53db5c92","status":"active","name":"recurrent malignant pleural effusion","description":"Repeated malignant pleural effusion targeted for preventive palliative treatment in the enrolled patients.","types":["condition"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_24a56c91850d55fdd8b810db53db5c92"},{"public_id":"co_251e86a11facfb674c8d82f91951c11d","status":"active","name":"symptomatic relief","description":"Improvement in symptoms after pleurodesis treatment for malignant pleural effusion.","types":["clinical outcome"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_251e86a11facfb674c8d82f91951c11d"},{"public_id":"co_350c78f2cd3c128db7269018055eb341","status":"active","name":"recurrence of significant pleural effusion requiring intervention","description":"Return of clinically important pleural effusion at follow-up that required another intervention.","types":["clinical outcome"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_350c78f2cd3c128db7269018055eb341"},{"public_id":"co_633becdf2c7ee17526e2102c8d98c975","status":"active","name":"malignant pleural effusion","description":"A pleural fluid accumulation associated with metastatic or neoplastic disease in the patients described.","types":["condition"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_633becdf2c7ee17526e2102c8d98c975"},{"public_id":"co_6f0e8c255efe8cb8d7aade6de6ad8c90","status":"active","name":"Talc Powder Pleurodesis","description":"A pleurodesis intervention using talc powder administered through a chest drain in group A.","types":["intervention"],"aliases":["TPP","Talc pleurodesis"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_6f0e8c255efe8cb8d7aade6de6ad8c90"},{"public_id":"co_8628c4c949ba5e53b57df6b0b9c8784f","status":"active","name":"post-procedure fever","description":"A fever above 38°C recorded within 48 hours after the pleurodesis procedure.","types":["adverse event"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_8628c4c949ba5e53b57df6b0b9c8784f"},{"public_id":"co_acaf0ca91b4554a1e5562d958f687fc0","status":"active","name":"in-hospital deaths","description":"Deaths occurring during the hospital admission after the pleurodesis procedure.","types":["safety outcome"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_acaf0ca91b4554a1e5562d958f687fc0"},{"public_id":"co_c499a2c3d0297b38f481aeba66332970","status":"active","name":"prospective randomized trial","description":"The clinical study design used to assign neoplastic patients to the two pleurodesis treatments.","types":["study design"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_c499a2c3d0297b38f481aeba66332970"},{"public_id":"co_f120ac9952356d686ddb8672ed0c1507","status":"active","name":"Povidone-iodine Pleurodesis","description":"A pleurodesis intervention using povidone-iodine administered through a chest drain in group B.","types":["intervention"],"aliases":["PIP"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"}],"url":"https://sah.borca.ai/concepts/co_f120ac9952356d686ddb8672ed0c1507"}],"external_ids":{"DOI":"10.1186/s13019-015-0270-5","ArXiv":null,"PubMed":25947235,"PubMedCentral":"4423097","MAG":2033139717,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://cardiothoracicsurgery.biomedcentral.com/counter/pdf/10.1186/s13019-015-0270-5","landing_url":"https://www.semanticscholar.org/paper/fc247fd42014c021b532d6713f2dd6e9e1cd20e7","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631974,"paper_uid":"34414af3-eac3-4ccd-b71b-bb7473d6d291","canonical_identity":{"paper_id":631974,"paper_uid":"34414af3-eac3-4ccd-b71b-bb7473d6d291","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/2758151"}